Australia markets closed

ALK-Abelló A/S (0OIR.IL)

IOB - IOB Delayed price. Currency in DKK
Add to watchlist
149.450.00 (0.00%)
At close: 03:54PM BST
Full screen
Loading interactive chart…
  • GlobeNewswire

    Three-month interim report (Q1) 2024 (unaudited)

    Company release No. 11/2024 ALK delivers 10% organic revenue growth with operating profit up 41% in Q1 and upgrades outlookThe growth in ALK's overall sales was primarily driven by the European tablet sales, which were boosted by the inflow of new patients and improved pricing. Sales outside Europe had a soft start to the year, partly due to temporary sales fluctuations and phasing of product shipments to International markets. Outlook for full-year revenue growth now expected at 10-13% (previou

  • GlobeNewswire

    ALK upgrades its full-year revenue outlook

    ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that the 2024 full-year financial outlook has been updated. Revenue is now expected to grow by 10-13% in local currencies (previously: 9-12%). The full-year financial outlook has been updated mainly to reflect the recent development in European tablet sales. The EBIT margin is still expected to improve to 17-19% but the earnings outlook now includes one-off costs of approximately DKK 60 million related to optimization initiatives, whereas no suc

  • GlobeNewswire

    Invitation to the presentation of ALK’s first quarter results on Friday 3 May 2024

    ALK (ALKB:DC / OMX: ALK B / AKBLF) will publish its first quarter results in the morning of 3 May 2024. Later same day, the company will host a presentation for investors and analysts at 12:30 CET, where ALK’s management will comment on the first quarter results and outlook and be available for questions. ALK will be represented by Peter Halling, President & CEO, Claus Steensen Sølje, CFO and Per Plotnikof, VP, Head of IR. Live audio webcast The meeting will be audio webcasted live and be availa